Slideshows Images Quizzes

Eucrisa vs. Temovate

Are Eucrisa and Temovate the Same Thing?

Eucrisa (crisaborole) and Temovate (clobetasol propionate) are indicated for topical treatment of atopic dermatitis (eczema).

Temovate is also used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions and psoriasis.

Eucrisa and Temovate belong to different drug classes. Eucrisa is a phosphodiesterase 4 inhibitor and Temovate is a steroid.

What Are Possible Side Effects of Eucrisa?

Common side effects of Eucrisa include:

  • application site pain

What Are Possible Side Effects of Temovate?

Common side effects of Temovate include:

  • burning,
  • stinging,
  • itching,
  • dryness,
  • redness, or
  • rash at the application site when first applied to the skin. This should disappear in a few days as your body adjusts to Temovate.

Other side effects of Temovate include:

  • dry or cracking skin,
  • thinning or softening of your skin,
  • skin rash or irritation around your mouth,
  • swollen hair follicles,
  • temporary hair loss,
  • spider veins,
  • changes in color of treated skin,
  • blisters,
  • pimples,
  • acne,
  • crusting of treated skin,
  • extreme/unwanted hair growth,
  • "hair bumps" (folliculitis), or
  • stretch marks.

What is Eucrisa?

Eucrisa (crisaborole) ointment, 2%, for topical use is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.

What is Temovate?

Temovate (clobetasol propionate) is a topical (for the skin) steroid used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

What Drugs Interact With Eucrisa?

Eucrisa may interact with ther drugs..

What Drugs Interact With Temovate?

Temovate may interact with corticosteroids taken by mouth or drugs that lower the immune system. Tell your doctor about all medications you are taking.

How Should Eucrisa Be Taken?

The recommended maintenance dosage is 30 mg twice daily taken orally starting on Day 6, after 5 days of an initial schedule of titration dosing.

How Should Temovate Be Taken?

Temovate Cream or Ointment is applied topically (on the skin) to the affected areas twice daily. Treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used..

Reviewed on 8/7/2018

SOURCE:

Pfizer. Eucrisa Product Information.

https://www.eucrisa.com

DailyMed. Temovate Product Information.

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acecf5ab-dd5e-4046-ab47-b9ff415d4b2b

Health Solutions From Our Sponsors